Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Inhye Ahn, M.D.

Concepts (141)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Lymphocytic, Chronic, B-Cell35202416406.550 Why?
Adenine1820249872.950 Why?
Piperidines18202416562.410 Why?
Pyrazoles12202120072.120 Why?
Pyrimidines13202330271.680 Why?
Protein Kinase Inhibitors14202356651.030 Why?
Vidarabine220243360.990 Why?
Antineoplastic Agents122024136370.910 Why?
Tumor Suppressor Protein p533202129160.800 Why?
Lymphoma, B-Cell220229400.630 Why?
Pneumocystis carinii12016720.520 Why?
Pneumonia, Pneumocystis120162420.480 Why?
Antineoplastic Combined Chemotherapy Protocols72023117400.470 Why?
Antibodies, Bispecific320231960.470 Why?
Philadelphia Chromosome120131170.430 Why?
Safety1201711500.420 Why?
Drug Resistance, Neoplasm6202453050.410 Why?
Irritable Bowel Syndrome120174550.400 Why?
Herpes Zoster Vaccine22022490.370 Why?
Integrin alpha4beta1220231190.360 Why?
Multiple Myeloma3201651460.330 Why?
Warfarin1201714830.320 Why?
Cyclophosphamide2202422180.300 Why?
Apoptosis1202494880.290 Why?
Myeloproliferative Disorders120136130.280 Why?
Benzamides3202113700.280 Why?
Phospholipase C gamma220171310.270 Why?
Pyrazines3202112010.270 Why?
Follow-Up Studies72024391170.230 Why?
Lymphoma2202319010.230 Why?
Renal Insufficiency, Chronic1201722430.220 Why?
Tumor Microenvironment2202338740.210 Why?
Disease-Free Survival3202068140.210 Why?
Aged, 80 and over102021589560.200 Why?
Humans4320247614230.200 Why?
Aged1820211692350.200 Why?
Vaccines, Synthetic220226190.190 Why?
Treatment Outcome102024646510.190 Why?
Molecular Targeted Therapy2202428110.190 Why?
Proto-Oncogene Proteins c-bcl-22202414050.180 Why?
Leukemia, Hairy Cell12020820.180 Why?
Hepatitis B Vaccines120211850.170 Why?
Hypertension1201985420.170 Why?
Herpes Zoster120222530.170 Why?
Lymphoma, Follicular120234570.160 Why?
Antigens, CD19220214250.160 Why?
Atrial Fibrillation1201751270.160 Why?
Smith-Magenis Syndrome12017190.150 Why?
Immunotherapy3202346500.150 Why?
Cell Transformation, Neoplastic2201828240.150 Why?
Protein-Tyrosine Kinases2201724230.150 Why?
Prognosis52023296200.140 Why?
Chromosomes, Human, Pair 17120174180.130 Why?
Disease Progression32020135020.130 Why?
Male1820213607360.130 Why?
Immunity120219970.120 Why?
Sulfonamides1202419750.110 Why?
Mutation42023300450.110 Why?
Middle Aged1420212208260.110 Why?
Chromosome Deletion1201713870.110 Why?
Neoplasm, Residual1201810080.100 Why?
Switzerland220233240.100 Why?
Survival Rate32021127200.100 Why?
Hydroxyurea120132840.100 Why?
Thrombocythemia, Essential120131130.100 Why?
Antiviral Agents2202130570.100 Why?
Polycythemia Vera120131610.100 Why?
Female1420213925810.100 Why?
Transplantation, Autologous1201621160.100 Why?
Histone-Lysine N-Methyltransferase120166820.100 Why?
Salvage Therapy1201812640.100 Why?
Survival Analysis22020100890.090 Why?
Hodgkin Disease1201813780.090 Why?
Adult920212211480.090 Why?
Kaplan-Meier Estimate2201864790.090 Why?
Congresses as Topic220238030.080 Why?
Neoplasm Proteins1202036120.080 Why?
Receptors, Antigen, B-Cell220235450.070 Why?
Bone Marrow1201829100.070 Why?
CD8-Positive T-Lymphocytes1202145750.070 Why?
Quinazolines1201313710.070 Why?
Anemia1201615080.070 Why?
Clinical Trials as Topic1202180000.060 Why?
Repressor Proteins1201629850.060 Why?
Evidence-Based Medicine1201636870.060 Why?
High-Throughput Nucleotide Sequencing1201736390.060 Why?
Autoimmune Diseases1201622480.060 Why?
Neoplasm Staging12018111060.050 Why?
Comorbidity12017104980.050 Why?
Coronavirus Infections1202030820.050 Why?
Pneumonia, Viral1202032020.050 Why?
Cladribine12020340.050 Why?
Enzyme Induction120204520.040 Why?
Thrombosis1201329420.040 Why?
Hematopoietic Stem Cell Transplantation1201656700.040 Why?
Immunization, Passive120206160.040 Why?
Signal Transduction12021234410.040 Why?
Incidence12016213410.040 Why?
Single-Chain Antibodies120181110.040 Why?
RNA, Neoplasm120207500.040 Why?
Lymphocytosis120181210.030 Why?
Leukocytes, Mononuclear1202318430.030 Why?
Hematologic Diseases120204960.030 Why?
Immunity, Humoral120206060.030 Why?
Adjuvants, Immunologic1202110360.030 Why?
Animals320231684410.030 Why?
Mice, Inbred NOD1201818270.030 Why?
Mice, SCID1201826260.030 Why?
Immunoglobulin M1201815290.030 Why?
Drug Administration Schedule1202048520.030 Why?
Headache1202012560.020 Why?
Drug Therapy, Combination1202163090.020 Why?
Cell Adhesion1201830870.020 Why?
Disease Management1202125070.020 Why?
Anti-Inflammatory Agents1202018080.020 Why?
Tumor Cells, Cultured1201861320.020 Why?
Retrospective Studies22021805820.020 Why?
In Situ Hybridization, Fluorescence1201625100.020 Why?
Xenograft Model Antitumor Assays1201836020.020 Why?
Vaccination1202133810.020 Why?
Phosphatidylinositol 3-Kinases1201828630.020 Why?
Epigenesis, Genetic1202137980.020 Why?
Polymerase Chain Reaction1201760860.020 Why?
Antibodies, Monoclonal1202391790.020 Why?
Biopsy1201867660.020 Why?
Lymph Nodes1201834660.020 Why?
Cells, Cultured12021189640.020 Why?
Neoplasm Recurrence, Local1202392770.020 Why?
RNA, Messenger12020127960.020 Why?
Pain1202050710.020 Why?
Multivariate Analysis12018120580.010 Why?
T-Lymphocytes12021101940.010 Why?
Mice22023815090.010 Why?
Combined Modality Therapy1201685290.010 Why?
Proportional Hazards Models12018124560.010 Why?
DNA1201772190.010 Why?
Sensitivity and Specificity12017146640.010 Why?
Pandemics1202086410.010 Why?
Gene Expression Profiling1201694180.010 Why?
United States12021723390.010 Why?
Young Adult12016592070.010 Why?
Ahn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (141)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.